Takeda Pharmaceutical (TAK) Liabilities and Shareholders Equity (2017 - 2026)
Takeda Pharmaceutical (TAK) reported Liabilities and Shareholders Equity of $98.27 billion for the quarter ended Jun 30, 2026, up 1.5% from $96.79 billion a year earlier but down 0.6% from the prior quarter.
Powered by 
Analysis
Takeda Pharmaceutical (TAK) Liabilities and Shareholders Equity (2017 - 2026) Analysis & Trends
As of Mar 31, 2026, Takeda Pharmaceutical posted Liabilities and Shareholders Equity of $103.05 billion, up 10.2% from the prior year.
- Liabilities and Shareholders Equity has a five-year compound annual growth rate of -3.3% (years ended Mar 2021 to Mar 2026).
- By year, Liabilities and Shareholders Equity came in at $93.54 billion in the year ended Mar 31, 2025 (-10.7%), $104.77 billion in the year ended Mar 31, 2024 (+1.4%), $103.32 billion in the year ended Mar 31, 2023 (-12.0%) and $117.38 billion in the year ended Mar 31, 2022 (-3.6%).
- Five-year quarterly Liabilities and Shareholders Equity spans a low of $93.39 billion in the quarter ended Mar 31, 2025 and a high of $113.39 billion in the quarter ended Mar 31, 2022.
- Year over year, Liabilities and Shareholders Equity has now increased in each of the last four quarters, with an average decline of 1.1% over the last eight quarters.
- The high point for year-over-year Liabilities and Shareholders Equity in five years was the quarter ended Mar 31, 2026 (growth of 5.9%); the low point was the quarter ended Mar 31, 2025 (a decline of 8.4%).
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $98.91 billion (quarter ended Mar 31, 2026), $100.12 billion (quarter ended Dec 31, 2025) and $98.21 billion (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Takeda Pharmaceutical | 2.63 Bn | -23.88 Bn | 5.10 Bn | 98.27 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 98.27 Bn |
| Mar 31, 2026 | 98.91 Bn |
| Dec 31, 2025 | 100.12 Bn |
| Sep 30, 2025 | 98.21 Bn |
| Jun 30, 2025 | 96.79 Bn |
| Mar 31, 2025 | 93.39 Bn |
| Dec 31, 2024 | 99.37 Bn |
| Sep 30, 2024 | 97.70 Bn |
| Jun 30, 2024 | 104.25 Bn |
| Mar 31, 2024 | 101.95 Bn |
| Dec 31, 2023 | 96.22 Bn |
| Sep 30, 2023 | 102.98 Bn |
| Jun 30, 2023 | 107.94 Bn |
| Mar 31, 2023 | 105.52 Bn |
| Dec 31, 2022 | 95.59 Bn |
| Sep 30, 2022 | 105.63 Bn |
| Jun 30, 2022 | 108.76 Bn |
| Mar 31, 2022 | 113.39 Bn |
| Jun 30, 2021 | 115.62 Bn |
| Mar 31, 2021 | 121.99 Bn |
API Access
Takeda Pharmaceutical Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=TAK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "TAK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=TAK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();